View in EDS PDF Full Text

Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.

Saved in:
Bibliographic Details
Title: Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.
Authors: Chan A; Breast Clinical Trials Unit, Breast Cancer Research Centre-WA & Curtin University, Perth, Australia. Electronic address: arlenechan@me.com., Moy B; Breast Oncology Program, Massachusetts General Hospital Cancer Center, Boston, MA., Mansi J; Oncology & Haematology Clinical Trials, Guy's and St Thomas Hospital NHS Foundation Trust and Biomedical Research Centre, King's College, London, United Kingdom., Ejlertsen B; Department of Oncology, Rigshospitalet, Copenhagen, Denmark., Holmes FA; Texas Oncology/US Oncology Research, Houston, TX., Chia S; Medical Oncology, BC Cancer Agency, Vancouver, BC, Canada., Iwata H; Clinical Oncology, Aichi Cancer Center, Chikusa-ku, Nagoya, Japan., Gnant M; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Loibl S; Center for Hematology and Oncology Bethanien, Frankfurt, Germany., Barrios CH; Centro de Pesquisa em Oncologia, Hospital São Lucas, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil., Somali I; Department of Oncology, Dokuz Eylul Universitesi Tip Fakultesi Hastanesi Tibbi Onkoloji Anabilim Dali Mithatpaşa, Balçova, Izmir, Turkey., Smichkoska S; University Clinic for Radiotherapy and Oncology, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia., Martinez N; Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Alonso MG; Oncología Médica, Hospital Universitario Nuestra Señora de la Candelaria Ctra. Del Rosario, Sta. Cruz De Tenerife, Canarias., Link JS; Breastlink Medical Group, Inc, Santa Ana, CA., Mayer IA; Division of Hematology/Oncology, Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, TN., Cold S; Onkologisk Afdeling R, Odense University Hospital, Odense, Denmark., Murillo SM; Hospital Universitario Arnau Vilanova Servei d'Oncologia Mèdica i Hematologia, Lleida, Spain., Senecal F; Physician Medical Center, Northwest Medical Specialties PLLC, Tacoma, WA., Inoue K; Breast Oncology, Saitama Cancer Center, Kita-Adachi, Japan., Ruiz-Borrego M; Oncología, Hospital Universitario Virgen del Rocio, Seville, Spain., Hui R; Crown Princess Mary Cancer Centre, Westmead Hospital and University of Sydney, Sydney, NSW, Australia., Denduluri N; Virginia Cancer Specialists, Arlington, VA., Patt D; Texas Oncology - Round Rock, Austin, TX., Rugo HS; Department of Medicine (Hematology/Oncology), University of California San Francisco Comprehensive Cancer Center, San Francisco, CA., Johnston SRD; The Breast Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Bryce R; Puma Biotechnology Inc., Los Angeles, CA., Zhang B; Puma Biotechnology Inc., Los Angeles, CA., Xu F; Puma Biotechnology Inc., Los Angeles, CA., Wong A; Puma Biotechnology Inc., Los Angeles, CA., Martin M; Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, GEICAM, Universidad Complutense, Madrid, Spain.
Corporate Authors: ExteNET Study Group
Source: Clinical breast cancer [Clin Breast Cancer] 2021 Feb; Vol. 21 (1), pp. 80-91.e7. Date of Electronic Publication: 2020 Oct 06.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33183970
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chan+A%22">Chan A</searchLink>; Breast Clinical Trials Unit, Breast Cancer Research Centre-WA & Curtin University, Perth, Australia. Electronic address: arlenechan@me.com.<br /><searchLink fieldCode="AU" term="%22Moy+B%22">Moy B</searchLink>; Breast Oncology Program, Massachusetts General Hospital Cancer Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Mansi+J%22">Mansi J</searchLink>; Oncology & Haematology Clinical Trials, Guy's and St Thomas Hospital NHS Foundation Trust and Biomedical Research Centre, King's College, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ejlertsen+B%22">Ejlertsen B</searchLink>; Department of Oncology, Rigshospitalet, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Holmes+FA%22">Holmes FA</searchLink>; Texas Oncology/US Oncology Research, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Chia+S%22">Chia S</searchLink>; Medical Oncology, BC Cancer Agency, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Iwata+H%22">Iwata H</searchLink>; Clinical Oncology, Aichi Cancer Center, Chikusa-ku, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Gnant+M%22">Gnant M</searchLink>; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Loibl+S%22">Loibl S</searchLink>; Center for Hematology and Oncology Bethanien, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Barrios+CH%22">Barrios CH</searchLink>; Centro de Pesquisa em Oncologia, Hospital São Lucas, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil.<br /><searchLink fieldCode="AU" term="%22Somali+I%22">Somali I</searchLink>; Department of Oncology, Dokuz Eylul Universitesi Tip Fakultesi Hastanesi Tibbi Onkoloji Anabilim Dali Mithatpaşa, Balçova, Izmir, Turkey.<br /><searchLink fieldCode="AU" term="%22Smichkoska+S%22">Smichkoska S</searchLink>; University Clinic for Radiotherapy and Oncology, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia.<br /><searchLink fieldCode="AU" term="%22Martinez+N%22">Martinez N</searchLink>; Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Alonso+MG%22">Alonso MG</searchLink>; Oncología Médica, Hospital Universitario Nuestra Señora de la Candelaria Ctra. Del Rosario, Sta. Cruz De Tenerife, Canarias.<br /><searchLink fieldCode="AU" term="%22Link+JS%22">Link JS</searchLink>; Breastlink Medical Group, Inc, Santa Ana, CA.<br /><searchLink fieldCode="AU" term="%22Mayer+IA%22">Mayer IA</searchLink>; Division of Hematology/Oncology, Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, TN.<br /><searchLink fieldCode="AU" term="%22Cold+S%22">Cold S</searchLink>; Onkologisk Afdeling R, Odense University Hospital, Odense, Denmark.<br /><searchLink fieldCode="AU" term="%22Murillo+SM%22">Murillo SM</searchLink>; Hospital Universitario Arnau Vilanova Servei d'Oncologia Mèdica i Hematologia, Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Senecal+F%22">Senecal F</searchLink>; Physician Medical Center, Northwest Medical Specialties PLLC, Tacoma, WA.<br /><searchLink fieldCode="AU" term="%22Inoue+K%22">Inoue K</searchLink>; Breast Oncology, Saitama Cancer Center, Kita-Adachi, Japan.<br /><searchLink fieldCode="AU" term="%22Ruiz-Borrego+M%22">Ruiz-Borrego M</searchLink>; Oncología, Hospital Universitario Virgen del Rocio, Seville, Spain.<br /><searchLink fieldCode="AU" term="%22Hui+R%22">Hui R</searchLink>; Crown Princess Mary Cancer Centre, Westmead Hospital and University of Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Denduluri+N%22">Denduluri N</searchLink>; Virginia Cancer Specialists, Arlington, VA.<br /><searchLink fieldCode="AU" term="%22Patt+D%22">Patt D</searchLink>; Texas Oncology - Round Rock, Austin, TX.<br /><searchLink fieldCode="AU" term="%22Rugo+HS%22">Rugo HS</searchLink>; Department of Medicine (Hematology/Oncology), University of California San Francisco Comprehensive Cancer Center, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Johnston+SRD%22">Johnston SRD</searchLink>; The Breast Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Bryce+R%22">Bryce R</searchLink>; Puma Biotechnology Inc., Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Zhang+B%22">Zhang B</searchLink>; Puma Biotechnology Inc., Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Xu+F%22">Xu F</searchLink>; Puma Biotechnology Inc., Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Wong+A%22">Wong A</searchLink>; Puma Biotechnology Inc., Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Martin+M%22">Martin M</searchLink>; Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, GEICAM, Universidad Complutense, Madrid, Spain.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22ExteNET+Study+Group%22">ExteNET Study Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100898731%22">Clinical breast cancer</searchLink> [Clin Breast Cancer] 2021 Feb; Vol. 21 (1), pp. 80-91.e7. <i>Date of Electronic Publication: </i>2020 Oct 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100898731 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1938-0666 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215268209%22">15268209 </searchLink><i>NLM ISO Abbreviation: </i>Clin Breast Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33183970
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.clbc.2020.09.014
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 80
    Titles:
      – TitleFull: Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chan A
      – PersonEntity:
          Name:
            NameFull: Moy B
      – PersonEntity:
          Name:
            NameFull: Mansi J
      – PersonEntity:
          Name:
            NameFull: Ejlertsen B
      – PersonEntity:
          Name:
            NameFull: Holmes FA
      – PersonEntity:
          Name:
            NameFull: Chia S
      – PersonEntity:
          Name:
            NameFull: Iwata H
      – PersonEntity:
          Name:
            NameFull: Gnant M
      – PersonEntity:
          Name:
            NameFull: Loibl S
      – PersonEntity:
          Name:
            NameFull: Barrios CH
      – PersonEntity:
          Name:
            NameFull: Somali I
      – PersonEntity:
          Name:
            NameFull: Smichkoska S
      – PersonEntity:
          Name:
            NameFull: Martinez N
      – PersonEntity:
          Name:
            NameFull: Alonso MG
      – PersonEntity:
          Name:
            NameFull: Link JS
      – PersonEntity:
          Name:
            NameFull: Mayer IA
      – PersonEntity:
          Name:
            NameFull: Cold S
      – PersonEntity:
          Name:
            NameFull: Murillo SM
      – PersonEntity:
          Name:
            NameFull: Senecal F
      – PersonEntity:
          Name:
            NameFull: Inoue K
      – PersonEntity:
          Name:
            NameFull: Ruiz-Borrego M
      – PersonEntity:
          Name:
            NameFull: Hui R
      – PersonEntity:
          Name:
            NameFull: Denduluri N
      – PersonEntity:
          Name:
            NameFull: Patt D
      – PersonEntity:
          Name:
            NameFull: Rugo HS
      – PersonEntity:
          Name:
            NameFull: Johnston SRD
      – PersonEntity:
          Name:
            NameFull: Bryce R
      – PersonEntity:
          Name:
            NameFull: Zhang B
      – PersonEntity:
          Name:
            NameFull: Xu F
      – PersonEntity:
          Name:
            NameFull: Wong A
      – PersonEntity:
          Name:
            NameFull: Martin M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2021 Feb
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1938-0666
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Clinical breast cancer
              Type: main
ResultId 1